1. Home
  2. WST vs RIVN Comparison

WST vs RIVN Comparison

Compare WST & RIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • RIVN
  • Stock Information
  • Founded
  • WST 1923
  • RIVN 2009
  • Country
  • WST United States
  • RIVN United States
  • Employees
  • WST N/A
  • RIVN N/A
  • Industry
  • WST Medical/Dental Instruments
  • RIVN Auto Manufacturing
  • Sector
  • WST Health Care
  • RIVN Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • RIVN Nasdaq
  • Market Cap
  • WST 18.9B
  • RIVN 15.4B
  • IPO Year
  • WST N/A
  • RIVN 2021
  • Fundamental
  • Price
  • WST $246.18
  • RIVN $12.24
  • Analyst Decision
  • WST Buy
  • RIVN Hold
  • Analyst Count
  • WST 7
  • RIVN 21
  • Target Price
  • WST $332.50
  • RIVN $14.00
  • AVG Volume (30 Days)
  • WST 841.4K
  • RIVN 41.2M
  • Earning Date
  • WST 07-24-2025
  • RIVN 08-05-2025
  • Dividend Yield
  • WST 0.36%
  • RIVN N/A
  • EPS Growth
  • WST N/A
  • RIVN N/A
  • EPS
  • WST 6.68
  • RIVN N/A
  • Revenue
  • WST $2,960,200,000.00
  • RIVN $5,151,000,000.00
  • Revenue This Year
  • WST $5.70
  • RIVN $6.92
  • Revenue Next Year
  • WST $6.05
  • RIVN $37.66
  • P/E Ratio
  • WST $36.83
  • RIVN N/A
  • Revenue Growth
  • WST 2.90
  • RIVN 2.73
  • 52 Week Low
  • WST $187.43
  • RIVN $9.50
  • 52 Week High
  • WST $352.33
  • RIVN $17.15
  • Technical
  • Relative Strength Index (RSI)
  • WST 57.91
  • RIVN 43.42
  • Support Level
  • WST $237.18
  • RIVN $11.79
  • Resistance Level
  • WST $244.36
  • RIVN $12.35
  • Average True Range (ATR)
  • WST 5.82
  • RIVN 0.48
  • MACD
  • WST -0.41
  • RIVN -0.02
  • Stochastic Oscillator
  • WST 51.10
  • RIVN 29.65

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About RIVN Rivian Automotive Inc.

Rivian Automotive Inc is an automotive manufacturer that develops and builds electric vehicles ("EVs") as well as software and services. It launches its consumer vehicle business with the R1 platform consisting of two vehicles: the R1T, and the R1S. The company has two reportable segments: Automotive, which derives the majority of revenue, and Software and Services segment. The Automotive reportable segment derives its revenues and cost of revenues from the production and sale of new EVs and the sale of regulatory credits generated by the production and sale of EVs. The Software and services reportable segment derives its revenues and cost of revenues from remarketing, vehicle repair and maintenance services, and vehicle electrical architecture and software development services.

Share on Social Networks: